Columnist Ann Reynoso, who's now preparing for a bilateral lung transplant, is counting on her strength and perseverance to ...

The study, led by the University of East Anglia, also found people living furthest from a hospital pulmonary fibrosis center also had shorter life expectancy than those living closer. It is ...

Did you see this? Nearly 1 in 10 Americans have asthma. Here's what causes it.

Several years ago, my dad was diagnosed with pulmonary fibrosis. The news was a shock. At 84 years old, Daddy had been dedicated to his physical health for decades. He played tennis twice a week ...

Boehringer Ingelheim (BI) has announced positive top-line results from a late-stage study of its investigational ...

Topline data from FIBRONEER™-ILD show that the investigational compound nerandomilast met its primary endpoint, which was the absolute change ...

Idiopathic Pulmonary Fibrosis, the condition that led to the ... In the Indian scenario, patients have been seen to be living for at least 10 to 12 years from the onset of the disease.

Boehringer Ingelheim today revealed that the FIBRONEER-ILD trial of nerandomilast met its primary endpoint, which was the ...

Boehringer Ingelheim’s FIBRONEER-ILD phase III study of nerandomilast to treat progressive pulmonary fibrosis meets primary endpoint: Ingelheim, Germany Wednesday, February 12, ...

United Therapeutics (UTHR) announced full enrollment of the TETON 1 study evaluating the use of Tyvaso or treprostinil, inhalation solution or ...